
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI
[ Thu, Sep 22nd 2022 ]: WOPRAI

[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI
[ Wed, Sep 21st 2022 ]: WOPRAI

[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
[ Tue, Sep 20th 2022 ]: WOPRAI
Ryan Zimmerman Maintained (TMCI) at Strong Buy with Increased Target to $28 on, Sep 21st, 2022


🞛 This publication is a summary or evaluation of another publication
Ryan Zimmerman of BTIG, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Increased Target from $23 to $28 on, Sep 21st, 2022.
Ryan has made no other calls on TMCI in the last 4 months.
There is 1 other peer that has a rating on TMCI. Out of the 1 peers that are also analyzing TMCI, 0 agree with Ryan's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ryan
- Drew Ranieri of "Morgan Stanley" Maintained at Buy with Increased Target to $23 on, Wednesday, August 10th, 2022